Search

4 Jul 2023: A wealth of training and networking opportunities are available within the University's entrepreneurial ecosystem in Cambridge.

22 Feb 2023: PharmEnable aims to develop new treatments for conditions with significant unmet clinical need by designing highly complex molecules for addressing challenging biological targets. ... We are pleased to welcome on board our new investors and appreciate

13 Dec 2023: The periods for which your data will be held will be provided to you in a new privacy notice.

22 Feb 2023: It’s a real pleasure to be working with a new company that we know to have an excellent pedigree.”.

17 Jan 2023: Share:. Cambridge researchers have developed a new test that ‘fishes’ for multiple respiratory viruses at once, using single strands of DNA as ‘bait’, and that gives highly accurate results in under ... This work elegantly uses new technology to

22 Feb 2023: Inotec AMD, a maker of mobile medical devices designed to heal chronic, hypoxic wounds, secures investment from Amadeus Capital Partners.

13 Dec 2023: Mobile menu. Mobile menu. Search. back. back. back. back. back. Making a Subject Access Request. Under data protection legislation an individual has the right, subject to certain exemptions, to access information from organisations that process

22 Sep 2023: Share:. Industry specialists from across the continent came together to discover new technologies from four of the UK’s leading universities.

22 Feb 2023: benefits, as they provide ways to power sensors from ambient vibration, and permit the creation of new types of sensors with dramatically lower power consumption than before. ... This new capital will provide the resources to scale 8power’s engagement

5 Apr 2023: The funding round was oversubscribed and led by Mission Possible Capital, a new Swiss venture capital fund with founding partners who previously co-foundedand Redalpine Venture Partners. ... Nicolas Berg, Founding Partner, Mission Possible. Pause. Play.